20/10/2022 Institute spin-out, Enhanc3D Genomics, raises £10 million in Series A financing gene expression |3d genome |spin out |commercialisation |schoenfelder
26/05/2022 Institute spin-out, ENHANC3D GENOMICS goes from strength to strength gene expression |3d genome |spin out |commercialisation |schoenfelder
22/06/2020 Institute spin-out joins Start Codon’s business acceleration programme commercialisation |institute |3d genome |disease |spin out |dna |genome organisation |enhancers |schoenfelder
09/11/2018 Institute spin-out announces early exclusive licence of oncology-targeted Humabody® antibodies |babraham research campus |cancer |commercialisation |immunology |impact |spin out